Bladder Cancer Canada addresses resolution of BCG shortage for bladder cancerPatients with nonmuscle-invasive bladder cancer should receive full doses of BCG. Managing hyperkalemia caused by renin-angiotensin-aldosterone system inhibitors Strategies to reduce the risk of chronic hyperkalemia in patients being treated with RAAS inhibitors for chronic kidney disease, heart failure and other conditions New guidance on assessment and treatment of erectile dysfunction in men Canadian Urological Association reviews assessment and treatment of erectile dysfunction and addresses five key clinical questions. New brand of BCG now available in Canada for treatment of bladder cancer Availability of Verity-BCG will help overcome years of intravesical BCG shortage, dose rationing and dose reductions. Antibiotic course for UTI in men can be shortened Men with urinary tract infection (UTI) get as much benefit from a shorter, seven-day treatment with antibiotics as they do with a 14-day course. Pharmacists play critical role in de-stigmatizing urinary incontinence When pharmacists sense patients have an incontinence issue, it presents an opportunity for discussion. The starting point: reassuring patients they are not alone. Health Canada warns of possible graft rejection when oral tacrolimus formulations switched Immediate-, extended- and prolonged-release oral formulations of tacrolimus are not interchangeable Health Canada warns of possible graft rejection when oral tacrolimus formulations switched Immediate-, extended- and prolonged-release oral formulations of tacrolimus are not interchangeable New guidelines for managing recurrent uncomplicated urinary tract infections in women Aim to prevent inappropriate antibiotic use, reduce the risk of antibiotic resistance and improve clinical outcomes and quality of life Canagliflozin improves renal outcomes in type 2 diabetes patients with chronic kidney disease Reduces risk of kidney failure and cardiovascular events compared to placebo First Previous 4 5 6 7 8 Next Last
